Wafaa El-Sadr

Wafaa El-Sadr, MD, MPH, is the director of the International Center for AIDS Care and Treatment Programs (ICAP) and director of the Center for Infectious Disease Epidemiologic Research (CIDER) at the Columbia University Mailman School of Public Health. Dr. El-Sadr is Professor of Clinical Medicine and Epidemiology at Columbia University. Dr. El-Sadr earned her MD from Cairo University, a master's of public health degree in epidemiology from the Mailman School of Public Health at Columbia University, and a master's in public administration degree from the Kennedy School for Government at Harvard University. She is Board certified in Internal Medicine and Infectious Diseases.

Dr. El-Sadr led the Division of Infectious Diseases at Harlem Hospital for two decades, where she was instrumental in the development of an internationally recognized comprehensive HIV/AIDS and TB program focused on service, training and research. She has been the principal investigator of large number of grants funded through NIH, CDC, HRSA, New York State and New York City Departments of Health and was instrumental in furthering the understanding of the epidemiology of HIV and TB as well as to the identification of effective strategies for their prevention and treatment.

Since joining Mailman School of Public Health, Dr. El-Sadr established the Center for Infectious Diseases Epidemiologic Research (CIDER) to enhance the training and research opportunities in this discipline. She is principal investigator for several NIH-funded therapeutic and prevention research grants and leads several CDC-funded TB grants. She established a Domestic Prevention Working Group within the HIV Prevention Network in order to focus on domestic aspects of the HIV epidemic. Dr. El-Sadr also established and directs the International Center for AIDS Care and Treatment Programs (ICAP), a large center with more than 700 staff around the world. ICAP provides technical assistance in resource-limited countries for programs that focus on HIV prevention, care and treatment as well as related conditions. She also serves on several US and international committees. Her interests include program development, establishing systems that support high quality programs and contribution to the knowledge base in infectious diseases and other health threats that affect vulnerable communities in the US and internationally.